Biointaxis

About:

Biointaxis is a biotechnology company that develops and offers advance technology products for neurodegenerative diseases.

Website: http://biointaxis.com/

Top Investors: European Commission, Ministry of Science and Innovation of Spain

Description:

Biointaxis is a genomic treatment and technology development company. The current lead program develops a gene therapy treatment for Friedreich ataxia, a rare, inherited, progressive neurodegenerative disease that typically affects teenagers and young adults. They reestablished the neurological functions in mice models of friedreich ataxia.

Total Funding Amount:

3.05M EUR

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2019-07-01

Contact Email:

biointaxis(AT)biointaxis.com

Founders:

Antoni Matilla Dueñas, Ivelisse Sanchez

Number of Employees:

11-50

Last Funding Date:

2024-10-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai